THE LATEST: Divestitures of Complex Pipeline Pharmaceutical Products off the Table at the FTC February 9, 2018
THE LATEST: DOJ Price-Fixing Probe Demonstrates That Deal Risk Is Not the Only Antitrust Concern Merging Parties Should Keep in Mind June 15, 2017
DOJ Issues Business Review Letter Pertaining to SSO Policy on Standard-Essential Patents and RAND Commitments February 12, 2015